Home/Filings/4/0001493152-25-013919
4//SEC Filing

Rachman Ilya M 4

Accession 0001493152-25-013919

CIK 0001873835other

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 5:20 PM ET

Size

5.0 KB

Accession

0001493152-25-013919

Insider Transaction Report

Form 4
Period: 2025-09-17
Rachman Ilya M
DirectorCEO and Chairman
Transactions
  • Purchase

    Common Stock

    2025-09-17$2.02/sh+2,500$5,0501,140,937 total
Footnotes (1)
  • [F1]Volume-weighted average price of purchases which transactions occurred at purchase prices from $2.01 to $2.02 per share, inclusive. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1
  • filerCIK 0001889334

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 5:20 PM ET
Size
5.0 KB